Lyell Immunopharma LYEL
NASDAQ LYEL
$9.63 -0.11 (-1.13%)
At close: Sep 29, 2026 · 4:00 PM EDT

Lyell Immunopharma (LYEL) Total Current Liabilities (2020 - 2026)

Updated

Lyell Immunopharma's Total Current Liabilities was $39.87 million in Q2 2026, up 8.0% from $36.9 million a year earlier and up 7.9% from the prior quarter.

Analysis

Lyell Immunopharma (LYEL) Total Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at Lyell Immunopharma came in at $49.41 million, down 8.1% from FY2024.

  • Total Current Liabilities shows a five-year compound annual growth rate of 0.1% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $53.79 million in FY2024 (+55.8%), $34.52 million in FY2023 (-6.8%), $37.03 million in FY2022 (-20.8%) and $46.74 million in FY2021 (-5.2%).
  • Quarterly Total Current Liabilities has moved between $30.8 million (Q1 2023) and $59.28 million (Q3 2021) over five years.
  • Compared with a year earlier, Total Current Liabilities was higher in four of the last eight quarters, with growth averaging 10.4%.
  • The best year-over-year quarter for Total Current Liabilities over five years was Q4 2024 (growth of 55.8%); the worst was Q2 2023 (a decline of 31.6%).
  • Per Business Quant data, LYEL's Total Current Liabilities in the three quarters before Q2 2026 was $36.95 million (Q1 2026), $49.41 million (Q4 2025) and $31.88 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Lyell Immunopharma 227.89 Mn 227.89 Mn - 39.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.87 Mn
Mar 31, 2026 36.95 Mn
Dec 31, 2025 49.41 Mn
Sep 30, 2025 31.88 Mn
Jun 30, 2025 36.90 Mn
Mar 31, 2025 41.29 Mn
Dec 31, 2024 53.79 Mn
Sep 30, 2024 33.51 Mn
Jun 30, 2024 30.88 Mn
Mar 31, 2024 32.35 Mn
Dec 31, 2023 34.52 Mn
Sep 30, 2023 35.06 Mn
Jun 30, 2023 34.39 Mn
Mar 31, 2023 30.80 Mn
Dec 31, 2022 37.03 Mn
Sep 30, 2022 51.22 Mn
Jun 30, 2022 50.29 Mn
Mar 31, 2022 41.06 Mn
Dec 31, 2021 46.74 Mn
Sep 30, 2021 59.28 Mn
API Access

Lyell Immunopharma Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=LYEL&period=max&api_key=YOUR_API_KEY